Related stories
Rhythm Pharmaceuticals Q3 Net Loss Narrows 22% to $41.37 Million
M impact | EQUITY | Nov 03, 2026, 12:20 PM UTC
Upstart Q3 2026 operating profit rises 52% year over year
Upstart reported operating profit up 52% year over year in Q3 2026.
M impact | EQUITY | Nov 03, 2026, 12:10 PM UTC
Vital Farms Swings to $6.46 Million Q3 Net Loss
Vital Farms reported a $6.46 million net loss in Q3 2026, compared with a profit a year earlier.
M impact | EQUITY | Nov 03, 2026, 12:10 PM UTC
Rockpoint Gas Storage Q2 Net Earnings Rise
M impact | EQUITY | Nov 03, 2026, 12:10 PM UTC
Shopify Shares Fall 16.2% Premarket After Q3 Results
M impact | EQUITY | Nov 03, 2026, 12:10 PM UTC
Seres Therapeutics Says SER-155 Cut Infection Risk 77% in Phase 1b Trial
The Phase 1b trial reported a 77% reduction in bloodstream infection risk.
L impact | EQUITY | Nov 03, 2026, 12:10 PM UTC